Model for tumour growth with treatment by continuous and pulsed chemotherapy

In this work we investigate a mathematical model describing tumour growth under a treatment by chemotherapy that incorporates time-delay related to the conversion from resting to hunting cells. We study the model using values for the parameters according to experimental results and vary some parameters relevant to the treatment of cancer. We find that our model exhibits a dynamical behaviour associated with the suppression of cancer cells, when either continuous or pulsed chemotherapy is applied according to clinical protocols, for a large range of relevant parameters. When the chemotherapy is successful, the predation coefficient of the chemotherapic agent acting on cancer cells varies with the infusion rate of chemotherapy according to an inverse relation. Finally, our model was able to reproduce the experimental results obtained by Michor and collaborators [Nature 435 (2005) 1267] about the exponential decline of cancer cells when patients are treated with the drug glivec.

[1]  M. Schrappe,et al.  Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study , 2005, The Lancet.

[2]  A. Murugan,et al.  Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls. , 2007, Mathematical biosciences.

[3]  D. Chaussabel,et al.  Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. , 2013, Blood.

[4]  Ram Rup Sarkar,et al.  Cancer self remission and tumor stability-- a stochastic approach. , 2005, Mathematical biosciences.

[5]  Martin A. Nowak,et al.  Dynamics of cytotoxic T–lymphocyte exhaustion , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[6]  T. Maiwald,et al.  Materials and Methods SOM Text Figs. S1 to S16 References Materials and Methods , 2022 .

[7]  D. Stoler,et al.  Cancer: the evolved consequence of a destabilized genome , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[8]  A. Brú,et al.  The universal dynamics of tumor growth. , 2003, Biophysical journal.

[9]  Murilo S. Baptista,et al.  How complex a dynamical network can be , 2011 .

[10]  J. Kopec,et al.  Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Ami Radunskaya,et al.  A delay differential equation model for tumor growth , 2003, Journal of mathematical biology.

[12]  Sandip Banerjee,et al.  Delay-induced model for tumor-immune interaction and control of malignant tumor growth , 2008, Biosyst..

[13]  R. Baserga,et al.  THE RELATIONSHIP OF THE CELL CYCLE TO TUMOR GROWTH AND CONTROL OF CELL DIVISION: A REVIEW. , 1965, Cancer research.

[14]  Frank Nani,et al.  A chemotherapy model for the treatment of cancer with metastasis , 2002 .

[15]  J. Uhr,et al.  Tumor dormancy. I. Regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex. , 1986, Journal of immunology.

[16]  S. Ruan,et al.  Stable periodic oscillations in a two-stage cancer model of tumor and immune system interactions. , 2012, Mathematical biosciences and engineering : MBE.

[17]  D. Berry,et al.  Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Jooyoung Park,et al.  Drug scheduling of cancer chemotherapy based on natural actor-critic approach , 2011, Biosyst..

[19]  Martin A. Nowak,et al.  Dynamics of chronic myeloid leukaemia , 2005, Nature.

[20]  N. Petrelli,et al.  Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. R. Lopes,et al.  On a cellular automaton with time delay for modelling cancer tumors , 2011, Journal of Physics: Conference Series.

[22]  A. Perelson,et al.  Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.

[23]  Ami Radunskaya,et al.  The dynamics of an optimally controlled tumor model: A case study , 2003 .